1518 related articles for article (PubMed ID: 19222207)
1. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
2. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
3. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
[TBL] [Abstract][Full Text] [Related]
4. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
5. MS-325: albumin-targeted contrast agent for MR angiography.
Lauffer RB; Parmelee DJ; Dunham SU; Ouellet HS; Dolan RP; Witte S; McMurry TJ; Walovitch RC
Radiology; 1998 May; 207(2):529-38. PubMed ID: 9577506
[TBL] [Abstract][Full Text] [Related]
6. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
[TBL] [Abstract][Full Text] [Related]
7. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
Ladd DL; Hollister R; Peng X; Wei D; Wu G; Delecki D; Snow RA; Toner JL; Kellar K; Eck J; Desai VC; Raymond G; Kinter LB; Desser TS; Rubin DL
Bioconjug Chem; 1999; 10(3):361-70. PubMed ID: 10346865
[TBL] [Abstract][Full Text] [Related]
8. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
[TBL] [Abstract][Full Text] [Related]
9. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
Werner EJ; Datta A; Jocher CJ; Raymond KN
Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
[TBL] [Abstract][Full Text] [Related]
11. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
12. Dendrimeric gadolinium chelate with fast water exchange and high relaxivity at high magnetic field strength.
Pierre VC; Botta M; Raymond KN
J Am Chem Soc; 2005 Jan; 127(2):504-5. PubMed ID: 15643857
[TBL] [Abstract][Full Text] [Related]
13. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM
J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170
[TBL] [Abstract][Full Text] [Related]
14. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
15. Species dependence on plasma protein binding and relaxivity of the gadolinium-based MRI contrast agent MS-325.
Eldredge HB; Spiller M; Chasse JM; Greenwood MT; Caravan P
Invest Radiol; 2006 Mar; 41(3):229-43. PubMed ID: 16481905
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a high relaxivity manganese(II)-based MRI contrast agent.
Troughton JS; Greenfield MT; Greenwood JM; Dumas S; Wiethoff AJ; Wang J; Spiller M; McMurry TJ; Caravan P
Inorg Chem; 2004 Oct; 43(20):6313-23. PubMed ID: 15446878
[TBL] [Abstract][Full Text] [Related]
17. Coupling fast water exchange to slow molecular tumbling in Gd3+ chelates: why faster is not always better.
Avedano S; Botta M; Haigh JS; Longo DL; Woods M
Inorg Chem; 2013 Aug; 52(15):8436-50. PubMed ID: 23841587
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
Xu J; Churchill DG; Botta M; Raymond KN
Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797
[TBL] [Abstract][Full Text] [Related]
19. Gold nanoparticles functionalised with fast water exchanging Gd3+ chelates: linker effects on the relaxivity.
Ferreira MF; Gonçalves J; Mousavi B; Prata MI; Rodrigues SP; Calle D; López-Larrubia P; Cerdan S; Rodrigues TB; Ferreira PM; Helm L; Martins JA; Geraldes CF
Dalton Trans; 2015 Mar; 44(9):4016-31. PubMed ID: 25611006
[TBL] [Abstract][Full Text] [Related]
20. Relaxometric evaluation of novel manganese(II) complexes for application as contrast agents in magnetic resonance imaging.
Aime S; Anelli L; Botta M; Brocchetta M; Canton S; Fedeli F; Gianolio E; Terreno E
J Biol Inorg Chem; 2002 Jan; 7(1-2):58-67. PubMed ID: 11862541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
